BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«D-Alanine Transaminase

Below is an extended D-Alanine Transaminase research listing. Click here to return to the D-Alanine Transaminase main in depth entry.

Recent Publications on D-Alanine Transaminase:

Genome-scale model for Clostridium acetobutylicum: Part II. Development of specific proton flux states and numerically determined sub-systems.
A regulated genome-scale model for Clostridium acetobutylicum ATCC 824 was...
Direct Link
4th September, 2008
Delaware Biotechnology Institute, University of Delaware, 15 Innovation
D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis.
We generated by allelic replacement a DeltadltA mutant of a virulent...
Direct Link
8th August, 2008
Groupe de Recherche sur les Maladies Infectieuses du Porc and Centre de
Verapamil modulates LPS-induced cytokine production via inhibition of NF-kappa B activation in the liver.
OBJECTIVE: To investigate the effect of verapamil on Lipopolysaccharide...
Direct Link
31st July, 2007
School of Medicine, Nanjing University, Department of General Surgery,
Targeted screening for genetic haemochromatosis: a combined phenotype/genotype approach.
OBJECTIVE: To evaluate the clinical utility of a targeted screening...
Direct Link
14th July, 2006
Department of Haematology, Royal Albert Edward Infirmary, Wigan, UK.
Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats.
The present study was designed to examine the hypothesis that liver tissue...
Direct Link
23rd May, 2006
Department of Toxicology, College of Pharmacy, The University of Louisiana
Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli.
High-level production of human leptin by fed-batch culture of recombinant...
Direct Link
18th February, 2005
Department of Chemical and Biomolecular Engineering and BioProcess
[Analysis on quality control of blood in blood banks in a five-year program in Hunan province] 16th December, 2004
Hunan Center for Clinical Laboratory, Changsha 410008, China.
Traditional markers of excessive alcohol use. 3rd April, 2004
Drug Heath Services, Royal Prince Alfred Hospital, Camperdown, NSW,
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. 24th March, 2004
School of Medicine, University of Queensland, and Department of Nutrition
A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development.
To investigate differences in the effect of interferon (IFN) -alpha and...
Direct Link
28th February, 2004
Department of Environmental Medicine and Infectious Diseases, Faculty of
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
A study was performed in 10 European health care centers in which 914...
Direct Link
24th February, 2004
Hospital Carlos III, Madrid, Spain.
[Single factor study of prognosis from 520 cases with chronic severe hepatitis] 13th November, 2003
The 302nd Hospital of PLA, Beijing 100039,China.
Serum alanine aminotransferase concentrations in patients with Kawasaki disease. 7th November, 2003
Department of Public Health, Jichi Medical School, 3311-1 Yakushiji
Can preconditioning reduce laparoscopy-induced tissue injury?
BACKGROUND: Pneumoperitoneum (P) created to facilitate laparoscopy (L) is...
Direct Link
30th August, 2003
Department of General Surgery, Faculty of Medicine, Afyon Kocatepe
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares. 30th July, 2003
U.O. Gastroenterologia e Epatologia, Azienda Ospedaliera Pisana e
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional